Molecular Basis of Acute Cystitis Reveals Susceptibility Genes and Immunotherapeutic Targets.

Tissue damage is usually regarded as a necessary price to pay for successful elimination of pathogens by the innate immune defense. Yet, it is possible to distinguish protective from destructive effects of innate immune activation and selectively attenuate molecular nodes that create pathology. Here...

Full description

Bibliographic Details
Main Authors: Ines Ambite, Manoj Puthia, Karoly Nagy, Caterina Cafaro, Aftab Nadeem, Daniel S C Butler, Gustav Rydström, Nina A Filenko, Björn Wullt, Thomas Miethke, Catharina Svanborg
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-10-01
Series:PLoS Pathogens
Online Access:http://europepmc.org/articles/PMC5061333?pdf=render
_version_ 1811289269337063424
author Ines Ambite
Manoj Puthia
Karoly Nagy
Caterina Cafaro
Aftab Nadeem
Daniel S C Butler
Gustav Rydström
Nina A Filenko
Björn Wullt
Thomas Miethke
Catharina Svanborg
author_facet Ines Ambite
Manoj Puthia
Karoly Nagy
Caterina Cafaro
Aftab Nadeem
Daniel S C Butler
Gustav Rydström
Nina A Filenko
Björn Wullt
Thomas Miethke
Catharina Svanborg
author_sort Ines Ambite
collection DOAJ
description Tissue damage is usually regarded as a necessary price to pay for successful elimination of pathogens by the innate immune defense. Yet, it is possible to distinguish protective from destructive effects of innate immune activation and selectively attenuate molecular nodes that create pathology. Here, we identify acute cystitis as an Interleukin-1 beta (IL-1β)-driven, hyper-inflammatory condition of the infected urinary bladder and IL-1 receptor blockade as a novel therapeutic strategy. Disease severity was controlled by the mechanism of IL-1β processing and mice with intact inflammasome function developed a moderate, self-limiting form of cystitis. The most severe form of acute cystitis was detected in mice lacking the inflammasome constituents ASC or NLRP-3. IL-1β processing was hyperactive in these mice, due to a new, non-canonical mechanism involving the matrix metalloproteinase 7- (MMP-7). ASC and NLRP-3 served as transcriptional repressors of MMP7 and as a result, Mmp7 was markedly overexpressed in the bladder epithelium of Asc-/- and Nlrp3-/- mice. The resulting IL-1β hyper-activation loop included a large number of IL-1β-dependent pro-inflammatory genes and the IL-1 receptor antagonist Anakinra inhibited their expression and rescued susceptible Asc-/- mice from bladder pathology. An MMP inhibitor had a similar therapeutic effect. Finally, elevated levels of IL-1β and MMP-7 were detected in patients with acute cystitis, suggesting a potential role as biomarkers and immunotherapeutic targets. The results reproduce important aspects of human acute cystitis in the murine model and provide a comprehensive molecular framework for the pathogenesis and immunotherapy of acute cystitis, one of the most common infections in man.The clinical studies were approved by the Human Ethics Committee at Lund University (approval numbers LU106-02, LU236-99 and Clinical Trial Registration RTP-A2003, International Committee of Medical Journal Editors, www.clinicaltrials.gov).
first_indexed 2024-04-13T03:51:55Z
format Article
id doaj.art-179d246158654051a6907866773658fa
institution Directory Open Access Journal
issn 1553-7366
1553-7374
language English
last_indexed 2024-04-13T03:51:55Z
publishDate 2016-10-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj.art-179d246158654051a6907866773658fa2022-12-22T03:03:47ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742016-10-011210e100584810.1371/journal.ppat.1005848Molecular Basis of Acute Cystitis Reveals Susceptibility Genes and Immunotherapeutic Targets.Ines AmbiteManoj PuthiaKaroly NagyCaterina CafaroAftab NadeemDaniel S C ButlerGustav RydströmNina A FilenkoBjörn WulltThomas MiethkeCatharina SvanborgTissue damage is usually regarded as a necessary price to pay for successful elimination of pathogens by the innate immune defense. Yet, it is possible to distinguish protective from destructive effects of innate immune activation and selectively attenuate molecular nodes that create pathology. Here, we identify acute cystitis as an Interleukin-1 beta (IL-1β)-driven, hyper-inflammatory condition of the infected urinary bladder and IL-1 receptor blockade as a novel therapeutic strategy. Disease severity was controlled by the mechanism of IL-1β processing and mice with intact inflammasome function developed a moderate, self-limiting form of cystitis. The most severe form of acute cystitis was detected in mice lacking the inflammasome constituents ASC or NLRP-3. IL-1β processing was hyperactive in these mice, due to a new, non-canonical mechanism involving the matrix metalloproteinase 7- (MMP-7). ASC and NLRP-3 served as transcriptional repressors of MMP7 and as a result, Mmp7 was markedly overexpressed in the bladder epithelium of Asc-/- and Nlrp3-/- mice. The resulting IL-1β hyper-activation loop included a large number of IL-1β-dependent pro-inflammatory genes and the IL-1 receptor antagonist Anakinra inhibited their expression and rescued susceptible Asc-/- mice from bladder pathology. An MMP inhibitor had a similar therapeutic effect. Finally, elevated levels of IL-1β and MMP-7 were detected in patients with acute cystitis, suggesting a potential role as biomarkers and immunotherapeutic targets. The results reproduce important aspects of human acute cystitis in the murine model and provide a comprehensive molecular framework for the pathogenesis and immunotherapy of acute cystitis, one of the most common infections in man.The clinical studies were approved by the Human Ethics Committee at Lund University (approval numbers LU106-02, LU236-99 and Clinical Trial Registration RTP-A2003, International Committee of Medical Journal Editors, www.clinicaltrials.gov).http://europepmc.org/articles/PMC5061333?pdf=render
spellingShingle Ines Ambite
Manoj Puthia
Karoly Nagy
Caterina Cafaro
Aftab Nadeem
Daniel S C Butler
Gustav Rydström
Nina A Filenko
Björn Wullt
Thomas Miethke
Catharina Svanborg
Molecular Basis of Acute Cystitis Reveals Susceptibility Genes and Immunotherapeutic Targets.
PLoS Pathogens
title Molecular Basis of Acute Cystitis Reveals Susceptibility Genes and Immunotherapeutic Targets.
title_full Molecular Basis of Acute Cystitis Reveals Susceptibility Genes and Immunotherapeutic Targets.
title_fullStr Molecular Basis of Acute Cystitis Reveals Susceptibility Genes and Immunotherapeutic Targets.
title_full_unstemmed Molecular Basis of Acute Cystitis Reveals Susceptibility Genes and Immunotherapeutic Targets.
title_short Molecular Basis of Acute Cystitis Reveals Susceptibility Genes and Immunotherapeutic Targets.
title_sort molecular basis of acute cystitis reveals susceptibility genes and immunotherapeutic targets
url http://europepmc.org/articles/PMC5061333?pdf=render
work_keys_str_mv AT inesambite molecularbasisofacutecystitisrevealssusceptibilitygenesandimmunotherapeutictargets
AT manojputhia molecularbasisofacutecystitisrevealssusceptibilitygenesandimmunotherapeutictargets
AT karolynagy molecularbasisofacutecystitisrevealssusceptibilitygenesandimmunotherapeutictargets
AT caterinacafaro molecularbasisofacutecystitisrevealssusceptibilitygenesandimmunotherapeutictargets
AT aftabnadeem molecularbasisofacutecystitisrevealssusceptibilitygenesandimmunotherapeutictargets
AT danielscbutler molecularbasisofacutecystitisrevealssusceptibilitygenesandimmunotherapeutictargets
AT gustavrydstrom molecularbasisofacutecystitisrevealssusceptibilitygenesandimmunotherapeutictargets
AT ninaafilenko molecularbasisofacutecystitisrevealssusceptibilitygenesandimmunotherapeutictargets
AT bjornwullt molecularbasisofacutecystitisrevealssusceptibilitygenesandimmunotherapeutictargets
AT thomasmiethke molecularbasisofacutecystitisrevealssusceptibilitygenesandimmunotherapeutictargets
AT catharinasvanborg molecularbasisofacutecystitisrevealssusceptibilitygenesandimmunotherapeutictargets